European Medicines Agency and European Food Safety Authority commit to a stronger collaboration

February 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …

Bayer UK/Ireland appoints new chief financial officer

February 9, 2012
Business Services, Sales and Marketing Bayer, Ute Bockstegers

Bayer has appointed Ms Ute Bockstegers as chief financial officer and head of business administration and partnering.Ute Bockstegers comes to …

Fate of Merck’s vorapaxar still unclear

February 8, 2012
Medical Communications, Sales and Marketing Merck, vorapaxar

Merck & Co’s blood thinner vorapaxar, designed to prevent blood clots and reduce heart attacks, is still causing bleeding in …

New drug discounts should be made transparent

February 8, 2012
Medical Communications, Sales and Marketing ABPI, NHS, NICE, access scheme, pricing

Patient access schemes agreed through NICE should be made more transparent.  This is according to Paul McManus, a pharmacist and …

GSK picture

GSK posts strong underlying sales growth

February 8, 2012
Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …

Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Merck prepares insomnia candidate

February 7, 2012
Sales and Marketing Merck, insomnia

Merck is to file its new insomnia drug suvorexant, with US regulators later this year. Suvorexant is an orexin receptor …

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …

Roche rounds off year with solid performance

February 3, 2012
Sales and Marketing Roche

A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results …

Andrew Morgan joins Republic M!

February 2, 2012
Business Services, Medical Communications, Sales and Marketing Andrew Morgan, Republic M!

Republic M! has strengthened its team with the appointment of Andrew Morgan as head of operations. Andrew has leadership expertise …

The Gateway to Local Adoption Series

Latest content